|
|
News Breaks
|
January 16, 2012
|
| 11:33 EDT |  | MNOV |
| theflyonthewall.com: | MedicNova and UC Boulder collaborate on brain injury therapy | | MediciNova and the Jasdaq Market of the Osaka Securities Exchange, and the University of Colorado , UC, Boulder disclosed a license agreement for the use of ibudilast (MN-166/AV411) for the treatment of post-traumatic brain injury, TBI. Led by the research of Daniel Barth, Ph.D., Professor of Neuroscience and Psychology at CU-Boulder, ibudilast demonstrated significant efficacy in a model of post-TBI anxiety, one of the most common disorders caused by TBI. :theflyonthewall.com |
|
|
News For MNOV From The Last 14 Days Check below for free stories on MNOV the last two weeks.
There are 2 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
May 23, 2012
|
| 16:03 EDT | | MNOV |
| | 16:01 EDT | | MNOV |
|
|
|
|
|
Subscribe for More Information